INTRODUCTION
Survival rates for very low birth weight (VLBW) neonates (birth weights 501 to 1500 g) have improved dramatically since the introduction of neonatal intensive care. 1 Improved survival for these VLBW neonates reflects advances in perinatal-neonatal medicine as well as a continuous change in attitudes regarding treatment of pregnancies and resuscitation of neonates at increasingly lower birth weights. 2 Our understanding of the temporal pattern of survival for all VLBW neonates and neonates of different racial and gender groups, however, is less clear. Knowledge of VLBW survival patterns may have important implications for resuscitation decisions and allocation of resources, especially if such decisions are based on arbitrary, outdated, or individual beliefs rather than recent evidence.
Previous VLBW survival studies found advantages for neonates of black race [3] [4] [5] [6] [7] and female gender 4, [8] [9] [10] [11] [12] that could not be explained by differences in gestational age. 8 Most of these studies relied on relatively short study periods and excluded neonates who died in the delivery room, died prior to transfer, were part of multifetal gestations, or had congenital anomalies. We examined a large inborn population of VLBW neonates including all liveborns delivered within a single institution over a 23-year period. Survival to hospital discharge for VLBW neonates by birth weight, race, gender, selected comorbidities, and presence of congenital anomalies were determined. We also evaluated whether differences in survival rates by race and gender could be explained by differences in delivery mode or application of artificial ventilation (continuous positive airway pressure and/or mechanical ventilation provided during neonatal stabilization or in the neonatal intensive care unit).
METHODS

Study Population
Data were obtained from an inception cohort of all liveborn VLBW neonates (elective terminations were excluded) at Parkland Memorial Hospital, the public hospital for Dallas County, Texas, between September 1, 1977 and December 31, 2000 (excluding the last 10 months of 1985). Data for 4873 VLBW neonates were prospectively abstracted from the medical record and entered into computerized databases by five research nurses. The computerized database was originally created as part of the Maternal and Neonatal Data Acquisition Transmission and Evaluation (MANDATE) project funded by the Robert Wood Johnson Foundation to assess the quality of perinatal-neonatal care. 13 Data abstraction lapsed for 10 months in 1985 and then continued using the original data definitions for relevant variables. Yearly analysis and presentation of the data to the Division of Neonatal-Perinatal Medicine by the database manager provided continuous quality control. The resulting database contains information on inborn VLBW neonates during the modern neonatology era. Elements from this database include birth weight, race, gender, survival status at hospital discharge, delivery mode, maternal age, artificial ventilation status, Apgar scores, presence of comorbidities (necrotizing enterocolitis, pneumothorax, and sepsis) and congenital anomalies, and multifetal gestation.
Data Definitions
Comorbidities that had consistent database definitions over the 23-year study period were used in the analysis. Unfortunately, definitions for respiratory distress syndrome, intraventricular hemorrhage, and chronic lung disease were not consistent over time and these conditions could not be used to assess mortality risk. In addition, data fields for surfactant use and high-frequency ventilation were added to the database January 1, 1994 and January 1, 1998, respectively, after the introduction of these therapies. Neonates with gastrointestinal dysfunction with signs Zstage 2 Bell's criteria 14 were designated as having necrotizing enterocolitis. Pneumothorax was defined as the presence of free air in the pleural cavity diagnosed by needle thoracentesis and/or chest X-ray. Sepsis was defined as the presence of a positive blood or cerebrospinal culture. Neonates with anomalies, malformations or deformations of the central nervous, genitourinary, musculoskeletal, pulmonary, cardiac, gastrointestinal, and/or other systems, or having a chromosomal abnormality were designated as having a congenital anomaly. Provision of intensive care was defined as at least providing neonates with active resuscitation in the delivery room.
In order to assess survival patterns for VLBW neonates within and across specific periods of time, the 23-year study period was divided into five epochs according to date of birth ( 
Statistical Analysis
We used a nonparametric trend test 15 to assess whether race, gender, multifetal gestation, maternal age, Apgar scores <4, delivery route, ventilation status, birth weight category distribution, occurrence of comorbidities, presence of congenital anomalies, and survival changed over time ( Table 2) .
In order to predict mortality risk (dependent outcome), we developed two logistic regression models. Firstly, a main effects model (Table 3a) was created to determine changes in mortality by epoch. The six race/gender subgroups were included in this model to control for changes in the racial composition of the sample over time. Independent variables included in the main effects model were birth weight, epoch of birth, maternal age, multifetal gestation, delivery mode, ventilation status, 1-minute Apgar scores <4, and presence of comorbidities and congenital anomalies. Secondly, a logistic regression model with epoch-specific interactions (Table 3b) for the factors included in the main effects model, excluding race/gender subgroups, was developed to predict mortality as a function of clinical and demographic variables and epoch of birth following risk adjustment methods. 16 Estimates for both models are expressed as odds ratios (OR) with 95% confidence intervals (CI). An odds ratio <1 implies that a parameter is associated with decreased mortality.
Estimates of mortality probabilities from the logistic interaction model were then used to predict race/gender standardized mortality ratios for each race/gender subgroup by epoch. Standardized mortality ratios (Table 4) were calculated following commonly used methods in epidemiology to summarize cohort study results. 17 Racial groups other than black, white, or Hispanic comprised <2% of the inborn population and were not included in the analysis. All analyses were conducted using Stata Statistical Software: Release 8.0. Finally, we assessed whether survival patterns could be explained by race/gender subgroup differences in delivery mode or application of artificial ventilation. In separate logistic regression analyses, Cesarean section and application of artificial ventilation were dependent variables. Adjusted odds ratios and 95% confidence intervals for Cesarean section rates by race/gender subgroups were estimated from a model using birth weight, maternal age, multiple birth, and epoch as independent variables (Table 5 ). Adjusted odds ratios and 95% CI for ventilation rates by race/gender subgroups were estimated from a model using birth weight, low 1-minute Apgar scores, and epoch as independent variables (Table 6 ). Significant differences in Cesarean delivery or ventilation by race/ gender subgroups would suggest a bias in clinician decisionmaking. 
RESULTS
There were 291,501 inborn live births at Parkland Memorial Hospital between September 1, 1977 and December 31, 2000; of these 4873 (1.67%) were VLBW. Selected demographic and perinatal characteristics of the study population are presented in Table 2 . The racial distribution of VLBW neonates changed during the 23-year study period, with a reduction in the proportion of black (62.3% to 37.4%) and white (24.6% to 7.4%) neonates and an increase in Hispanics (13.0% to 55.2%). The incidence of multifetal gestation and percentage of females was unchanged over time. The proportion of teenage mothers decreased 40%. While the proportion of Apgar scores <4 at 1 and 5 minutes declined, Cesarean section rates nearly doubled. Comorbidity rates varied by condition and over time. Necrotizing enterocolitis afflicted 7.1% to 13.0% of neonates. Rates of pneumothorax decreased significantly over time from 10.9% to 13.5% to approximately 5% in the surfactant era (p< 0.001). The incidence of sepsis was lowest in Epoch 1 (24%), and increased to 33% to 41% during Epochs 2 to 5. Finally, the proportion of VLBW neonates with congenital anomalies ranged from 4.7% to 6.9% and did not change over time.
Overall, VLBW survival improved between Epochs 1 and 4, increasing from 50.2% to 81.0%, but did not differ between Epochs 4 and 5 (Table 2) . Interepochal survival improvements decreased from 27% between Epochs 1 and 2, 14% between Epochs 2 and 3, 11% between Epochs 3 and 4, and no change between Epochs 4 and 5. Birth weight-specific survival in 100 g increments by epoch is illustrated in Figure 1 . For each epoch, the curves illustrate the influence of increasing birth weight on improved survival. During Epoch 1 survival was 1% (1/69), 61% (57/93), and 83% (103/124) for neonates with birth weights of 501 to 600, 1001 to 1100, and 1401 to 1500 g, respectively. Improvement in birth weight-specific survival over time is clearly demonstrated by the leftward shift of the epochal survival curves. This is illustrated by comparing Epoch 1 with Epoch 5, at which time survival rates were 18% (12/66), 90% (80/89), and 94% (147/157) for neonates with birth weights 501 to 600, 1001 to 1100, and 1401 to 1500 g, respectively. Improved survival is also seen when the birth weight at which 50% of VLBW neonates survived is examined. Using this approach, the birth weight corresponding to 50% survival decreased by B100 g per epoch with values falling from B1000 g in Epoch 1 to 700 g in Epochs 4 and 5. Table 3a provides the odds ratios and 95% CI for the main effects logistic regression model. Odds ratios for the impact of epoch on mortality risk controlling for the other parameters indicate substantial differences in Epochs 1 to 3 relative to Epoch 5, but no change in mortality risk between Epochs 4 and 5 (OR ¼ 1.00; 95% CI ¼ 0.73 to 1.37; P ¼ 0.99). By including variables for race and gender, we were able to document the substantial survival advantage of black females over all other race/ gender subgroups over the study period. Increasing birth weight, delivery by Cesarean section, and presence of sepsis were associated with improved survival. Maternal age, access to mechanical ventilation, and being part of a multifetal gestation had no impact on survival, while 1-minute Apgar score <4 and presence of necrotizing enterocolitis and pneumothorax were associated with increased mortality. Table 3b provides odds ratios and 95% CI for mortality risk of multifetal gestation, delivery mode, ventilation status, low 1-minute Apgar scores, selected comorbidities, and congenital anomalies interacted with Epochs 1 to 4 assessed relative to Epoch 5. While increasing birth weight was associated with improved survival, there was no impact on mortality for maternal age, multifetal gestation, and necrotizing enterocolitis. Delivery by Cesarean section was protective over time. Changes in mortality risk over time also are evidenced by artificial ventilation status. During Epoch 1, ventilation status was associated with increased risk of mortality as a large portion of neonates expired. By Epoch 4, ventilation status was associated with improved survival. There was decreased mortality risk over time with infants with low 1-minute Apgar scores. During Epochs 1 to 3, the mortality risk of pneumothorax declined; in Epoch 4 the risk increased. The odds ratios for mortality risk given sepsis indicate that sepsis was increasingly protective over the study period. Sepsis was likely a proxy for increased survival over the epochs and increased length of hospital stay. In addition, more neonates with sepsis were effectively treated over time, preventing mortality. In contrast, the odds ratios indicate steep changes in mortality for neonates born with congenital anomalies over time. Neonates born with congenital anomalies in Epoch 1 had >13-fold increased risk of mortality relative to Epoch 5 while odds of dying for neonates with congenital anomalies decreased to 4.77 by Epoch 4.
Predictions from the interaction model (Table 3b) demonstrate that the pattern of birth weight-specific survival was relatively unchanged over the entire study period: black females >black males ¼ white females ¼ Hispanic females>white males ¼ Hispanic males. The standardized mortality ratios (SMRs) presented in Table 4 indicate a significant reduction in observed to expected mortality for black females over the entire study period (SMR ¼ 0.75; 95% CI ¼ 0.66 to 0.85) and a significant increase for white and Hispanic males (SMR ¼ 1.28, 95% CI ¼ 1.07 to 1.50; and SMR ¼ 1.37, 95% CI ¼ 1.18 to 1.58, respectively). Altering the logistic regression model upon which the SMRs are based had little impact on the overall estimates. The estimated relationships appear robust to the inclusion or exclusion of selected comorbidities, congenital anomalies, or other potential confounders.
The large change in Cesarean section rates and increased access to artificial ventilation over time could have a significant impact on mortality if the differences varied systematically by race/gender subgroups. However, while both mode of delivery and application of artificial ventilation are associated with improved survival, neither one explains the observed difference in survival patterns. The odds ratios for all race/gender subgroups were not different from the reference group, black females, in either the Cesarean delivery model (Table 5 ) or the ventilation model (Table 6) .
DISCUSSION
This 23-year investigation of the pattern of VLBW survival is the longest and largest of its kind from a single American neonatal intensive care unit. The findings demonstrate dramatic improvements in survival during the modern neonatology era, most occurring prior to the surfactant era. While survival improved for all race/gender subgroups, black females maintained a survival advantage over all other subgroups throughout the study period. In an effort to explain the observed survival patterns, we explored whether any race/gender subgroup was more affected by comorbidities or congenital anomalies. In addition, we examined whether any race/gender subgroup was more likely to be delivered by Cesarean section or provided artificial ventilation. Both mode of delivery and access to artificial ventilation are possible explanations for differences in survival patterns by VLBW neonates that have not been addressed previously.
While the incidence of pneumothorax and congenital anomalies in black females was significantly less than in other race/gender subgroups, the low occurrence of these conditions had little impact on overall mortality differences. Similarly, we found no differences in rates of Cesarean delivery or access to artificial ventilation by the race/gender subgroups. Both mode of delivery and access to artificial ventilation were related to clinical condition at birth. The consequence of these analyses is to confirm the large survival advantage of black female VLBW neonates that cannot be explained by the available clinical information. Other investigators offer an alternative explanation for the observed difference in black and female VLBW neonates based upon differences in lung maturation. Studies have demonstrated accelerated lung maturation in black and female premature neonates compared to nonblacks and males. [18] [19] [20] Thus, a lower incidence and lower birth weight-specific mortality from respiratory distress syndrome (RDS) among blacks and females may contribute to their survival advantage. 7, 18, 20 This study does not provide data on RDS, as this condition was not identified consistently over the study period. However, the study provides some insight in understanding differences in survival patterns over time. We show a narrowing of the absolute difference in mortality by race/gender subgroups. Such a finding should not be confused with differences in relative survival. Black females maintained a large relative survival advantage over all other race/ gender subgroups throughout the 23-year study period.
This study also provides new data on Hispanics, a relatively understudied group in terms of VLBW survival. Because of the rising population of Hispanics (predominantly of Mexican origin) in Texas, we compared Hispanic VLBW survival rates to black and white neonates. VLBW Hispanic survival rates from our study are consistent with others 21 and very nearly identical to those for white VLBW neonates 7 despite having similar socioeconomic risk factors to blacks. There does not appear to be satisfactory explanations for this epidemiological paradox 22, 23 although societal, nutritional and/or behavioral explanations have been offered. 23, 24 While overall VLBW survival rates improved >60% during the study, consistent with observations from longitudinal studies during the 1970s to 1990s taken together, 4,11,12,21,25 -32 the largest gains in survival were observed at the beginning of the study period with improved survival leveling off during the most recent epoch. The deceleration in interepochal survival rates is a novel finding. Gains in survival rates over time were most pronounced prior to the surfactant era and were likely due to the development and introduction of specialized neonatal ventilators and premature enteral and parenteral nutrition, as well as an increased willingness of obstetricians to perform Cesarean deliveries for neonates <1 kg. Marginal improvements in survival rates were noted during the surfactant era, concurrent with the widespread use of high-frequency ventilation and antenatal and postnatal steroids. Despite increased use of high-frequency ventilation and antenatal steroids during the late 1990s, VLBW neonatal survival rates leveled off. Similar findings have been reported elsewhere with speculation that stagnation in VLBW survival could be due to limits in current technologies to improve survival, inappropriate use of therapies, and/or changing attitudes among health care professionals and families regarding appropriateness of continuing intensive care for some neonates. 33 We have no data supporting that inappropriate use of therapies or changing attitudes affected survival outcomes. Thus, it is possible that the deceleration in survival rates for VLBW neonates during the 1990s may indicate minimal possibilities for improvement with current neonatal therapies. 34 This study has a number of limitations. A major limitation of this single institution inborn study is that the effects of RDS, chronic lung disease, and intraventricular hemorrhage on mortality risk could not be investigated, as these comorbidities were not consistently identified over the study period. Analysis of other comorbidities, however, indicated substantial survival gains for neonates born with congenital anomalies and a reduction in the incidence of pneumothorax over time after controlling for differences in birth weight. Incorporating comorbidities into a mortality risk model, however, did not significantly influence race/ gender survival patterns and other studies need to address relative survival differences using similar risk-adjustment methods.
A second limitation is the focus on hospital survival rather than longer-term outcomes. Survival, however, remains an important objective outcome, and this study shows clear differences in race/ gender survival patterns as well as survival patterns over time. The study also is limited in that all survival information was based on the objective measure of birth weight, rather than the interaction of gestational age and birth weight. Assessment of gestational age, however, is often difficult and uncertain and therefore unreliable. 35 Finally, the study does not provide direct information regarding changes in obstetrical and neonatal management of preterm pregnancies and neonates. We assumed that the increased use of Cesarean section and increased ventilation of the smallest neonates indicated changes in attitude.
Based on this 23-year study period, we cannot identify any comorbidity or therapy that could explain the persistent survival advantages for black female VLBW neonates. We suspect that the survival advantage is due to biologic differences between groups. If this is true, then the observed patterns of survival have little to do with the differential impact of new therapies or clinician bias in treatment decisions.
The decision of whom to resuscitate and provide prolonged neonatal intensive care remains one of the most important decisions in the practice of neonatology. This study has shown that these decisions do not appear to be based on individual and outdated beliefs concerning survival probabilities. Still, the survival advantage of black female VLBW neonates persists in the current era although an explanation for these survival patterns remains unclear.
